Company Monitoring Page for Rexahn

latest headlines for company on cafepharma

Rexahn Pharmaceuticals Terminates Breast Cancer Study with Merck
BioSpace
Thu, 04/9/20 - 11:18 pm
Tags:
Rexahn, triple negative breast cancer, Merck, Keytruda
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Tue, 10/4/16 - 10:07 am
Tags:
FDA, clinical trials, Exelixis, cabozantinib, Cobimetinib, Celldex Therapeutics, CDX-011, Cerulean Pharma, CRLX101, Medivation, Xtandi, Palatin, bermelanotide, Rexahn, RX-3117, Anthera Pharmaceuticals
Rexahn's Human Data Confirms Anti-Cancer Advantage
Yahoo
Wed, 09/30/15 - 09:41 am
Tags:
Rexahn, RX-3117, Supinoxin, cancer
Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off
Seeking Alpha
Tue, 01/13/15 - 04:28 pm
Tags:
Rexahn, RX-3117, Eli Lilly, Gemzar, solid tumors
Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors
Pharmiweb
Sat, 07/19/14 - 09:05 am
Tags:
Supinoxin, Rexahn
Think Like a Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives on Six Exciting Biotechs
IT Business Net
Sat, 05/17/14 - 10:38 am
Tags:
Opexa, Biocryst, Rexahn, Corcept Therapeutics, Ligand Pharmaceuticals, MannKind
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff
Seeking Alpha
Mon, 04/21/14 - 04:46 pm
Tags:
Taxotere, Rexahn, RX-21101, patents, patent cliff, Bristol-Myers Squibb, Roche, Sanofi
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013
TheStreet.com
Tue, 01/21/14 - 09:37 am
Tags:
biotech, Intercept Pharma, Rexahn, CorMedix, Neurocrine, Cell Therapeutics
3 Biotechs Getting Plenty Of Attention From Investors
Seeking Alpha
Wed, 01/15/14 - 10:09 am
Tags:
Depomed, Rexahn, Cambia, Zipsor, Gralise, Cangene, Emergent BioSolutions
Why Rexahn Pharmaceuticals (RNN) Is Up Today
TheStreet.com
Fri, 01/10/14 - 10:56 am
Tags:
Rexahn, Archexin, Supinoxin, RX-3117
Rexahn: A Turn Around Story For 2014
Seeking Alpha
Mon, 12/23/13 - 09:59 am
Tags:
Rexahn, oncology
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
Seeking Alpha
Mon, 10/7/13 - 08:48 am
Tags:
Rexahn, chemotherapy, Amgen, Bristol-Myers Squibb, Merck, Novartis, Teva, RX-3117
Rexahn Regains Rights To Novel Cancer Drug As Teva Continues Its Pipeline Stumble
Seeking Alpha
Fri, 09/6/13 - 10:31 am
Tags:
Teva, Rexahn, RX-3117
Teva-Rexahn Deal Terminated - Analyst Blog
NASDAQ
Sat, 08/31/13 - 11:59 am
Tags:
Teva, Rexahn, RX-3117
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
Seeking Alpha
Tue, 08/6/13 - 10:49 am
Tags:
Rexahn, Merck, Novo Nordisk, Teva, Archexin, cancer
Rexahn awarded U.S. patent for novel anti-cancer compounds
Yahoo/Fly on the Wall
Mon, 06/17/13 - 09:49 am
Tags:
patents, Rexahn, quinazoline, anti-tumor
Rexahn says to continue RX-3117 development with Teva
The Fly on the Wall
Tue, 02/19/13 - 10:07 am
Tags:
Rexahn, RX-3117, Teva, RX-5902, Archexin
Rexahn Pharmaceuticals: Update On Cancer Drugs
Seeking Alpha
Fri, 05/18/12 - 11:00 am
Tags:
Teva Pharmaceuticals, Rexahn, Archexin, RX-3117, RX-5902, RX-8243, cancer, akt protein inhibitor
You Should Have Seen These Biotech Failures Coming
Motley Fool
Sat, 11/5/11 - 02:44 pm
Tags:
Oxigene, Rexahn
Rexahn Pharmaceuticals advances pancreatic cancer drug
Bizjournals.com
Wed, 09/28/11 - 12:31 pm
Tags:
Rexahn, pancreatic cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.